CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Clinical trial NCT03636269 · COMPLETED
Trial details
- NCT number
- NCT03636269
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2020-03-30
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.